ICON Public Limited Company (ICLR)
-NasdaqGS | Prev Close: | 33.39 |
|---|
| Open: | N/A |
|---|
| Bid: | N/A |
|---|
| Ask: | N/A |
|---|
| 1y Target Est: | 35.94 |
|---|
| Beta: | 0.59 |
|---|
| Next Earnings Date: | 22-Jul-13 |
|---|
| Day's Range: | N/A - N/A |
|---|
| 52wk Range: | 20.25 - 35.86 |
|---|
| Volume: | 0 |
|---|
| Avg Vol (3m): | 365,924 |
|---|
| Market Cap: | 2.02B |
|---|
| P/E (ttm): | 30.89 |
|---|
| EPS (ttm): | 1.08 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Quintiles Climbs 5% In Debut In A Busy Day, Week For IPOsInvestor's Business Daily(Thu, May 9)
- Pharmaceutical services provider Quintiles surges on first day of tradingat theflyonthewall.com(Thu, May 9)
- Quintiles, PennyMac, Cyan Lead Large IPO Packat Investor's Business Daily(Mon, May 6)
- Covance Beats Earnings, Rev, Ups ViewZacks(Mon, May 6)
- Stocks In Give-Back Mode; Spirit Air Flies, MasterCard Offat Investor's Business Daily(Wed, May 1)
- 3 Healthcare Stock Winners and 2 Losers After Earnings Are Digestedat Wall St. Cheat Sheet(Sun, Apr 28)
- David Ferreiro, Executive Director and Senior Analyst at Oppenheimer & Co. Inc., Interviews with The Wall Street Transcript: Opportunities in Hepatitis C and Genomic TechnologiesWall Street Transcript(Fri, Apr 26)
- ICON Public Limited Management Discusses Q1 2013 Results - Earnings Call Transcriptat Seeking Alpha(Thu, Apr 25)
- Analysts: Berkshire is Well Positioned For Earnings and 2 Other Research Notes to Read Nowat Wall St. Cheat Sheet(Thu, Apr 25)
- ICON Earnings: Here’s Why the Stock is Up Nowat Wall St. Cheat Sheet(Thu, Apr 25)
- ICON plc Earnings Call scheduled for 9:00 am ET todayCCBN(Thu, Apr 25)
- Q1 2013 ICON plc Earnings Release - Time Not SuppliedCCBN(Thu, Apr 25)
- ICON Reports First Quarter 2013 Revenue of $317 Million, up 26% year on year and non-GAAP EPS of 36c.Business Wire(Thu, Apr 25)
- ICON Wins ‘Partnership Pioneers of the Year’ Award in Recognition of Global Partnership with PfizerBusiness Wire(Wed, Apr 24)
- The “Healthy” Play In Contract Research Organizationsat Investopedia(Wed, Apr 17)
Comparison
| Symbol | % Chg | Mkt Cap |
|---|
| ICLR | 0.00% | 2.02B |
| TMO | 0.00% | 31.15B |
| WYETH.NS | 0.09% | 18.22B |
| WYETH.BO | 1.66% | 18.46B |
| A | 0.00% | 15.99B |
Key Statistics
| Forward P/E (1 yr): | 17.86 |
|---|
| P/S (ttm): | 1.71 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | 1.56 |
|---|
| Quarterly EPS Est
(Jun-13)
: | 0.38 |
|---|
| Mean Recommendation*: | 1.9 |
|---|
| PEG Ratio (5 yr expected): | 0.94 |
|---|
Business Summary
ICON Public Limited Company, a contract research organization, provides outsourced development services to the pharmaceutical, biotechnology, and medical device industries primarily in Ireland, the United States, and rest of Europe.
View More